- Home
- CHPT vs MRVI Comparison
CHPT vs MRVI Comparison
Compare CHPT & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHPT
- MRVI
- Stock Information
- Founded
- CHPT 2007
- MRVI 2014
- Country
- CHPT United States
- MRVI United States
- Employees
- CHPT N/A
- MRVI N/A
- Industry
- CHPT Industrial Specialties
- MRVI Biotechnology: Pharmaceutical Preparations
- Sector
- CHPT Consumer Discretionary
- MRVI Health Care
- Exchange
- CHPT Nasdaq
- MRVI Nasdaq
- Market Cap
- CHPT 321.7M
- MRVI 312.4M
- IPO Year
- CHPT N/A
- MRVI 2020
- Fundamental
- Price
- CHPT $0.70
- MRVI $2.24
- Analyst Decision
- CHPT Hold
- MRVI Hold
- Analyst Count
- CHPT 10
- MRVI 10
- Target Price
- CHPT $1.58
- MRVI $6.84
- AVG Volume (30 Days)
- CHPT 10.5M
- MRVI 1.9M
- Earning Date
- CHPT 06-04-2025
- MRVI 05-12-2025
- Dividend Yield
- CHPT N/A
- MRVI N/A
- EPS Growth
- CHPT N/A
- MRVI N/A
- EPS
- CHPT N/A
- MRVI N/A
- Revenue
- CHPT $417,083,000.00
- MRVI $241,856,000.00
- Revenue This Year
- CHPT $12.03
- MRVI N/A
- Revenue Next Year
- CHPT $26.85
- MRVI $11.28
- P/E Ratio
- CHPT N/A
- MRVI N/A
- Revenue Growth
- CHPT N/A
- MRVI N/A
- 52 Week Low
- CHPT $0.51
- MRVI $1.67
- 52 Week High
- CHPT $2.44
- MRVI $10.03
- Technical
- Relative Strength Index (RSI)
- CHPT 53.37
- MRVI 52.26
- Support Level
- CHPT $0.67
- MRVI $2.20
- Resistance Level
- CHPT $0.79
- MRVI $2.41
- Average True Range (ATR)
- CHPT 0.05
- MRVI 0.16
- MACD
- CHPT 0.00
- MRVI 0.02
- Stochastic Oscillator
- CHPT 30.61
- MRVI 59.14
About CHPT ChargePoint Holdings Inc.
ChargePoint Holdings Inc designs, develops, and markets networked electric vehicle charging system infrastructure and cloud-based services that enable consumers to locate, reserve, and authenticate EV charging. The company's hardware product lineup includes solutions across home, commercial, and fast-charging applications. ChargePoint derives the majority of its revenue from the United States.
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.